A recently listed domestic company has attracted market attention by releasing clinical data on its ring-type cuffless blood pressure measurement technology at an international conference held in Europe. Utilizing optical sensors and artificial intelligence, the device measures blood pressure for extended periods without compressing the arm. This presents the possibility of observing blood pressure changes in a wide range of patients, including those with atrial fibrillation and heart failure. As the base of domestic prescriptions expands, there is an outlook that accumulating clinical evidence and concrete overseas expansion could secure additional growth drivers.


For newly listed stocks, news of clinical announcements and business expansion may create new buying opportunities, but insufficient capital can make it difficult to respond at the proper time. By using stock financing products that can be leveraged up to four times the investor's available funds, one can make additional purchases of stocks of interest and expand investment targets; refinancing existing margin loans or unsettled trades is also an option. Before using such products, it is necessary to compare applicable interest rates, ancillary fees, collateral ratios, and repayment terms to establish a plan that ensures stable management.


HighStockLoan has maintained its No. 1 position in the industry for 22 years, offering a variety of stock financing products, including annual interest rate products in the 5% range. It can be used to prepare new investment funds or to manage funds through refinancing margin and unsettled trades, making it an option of interest for investors seeking to secure investment opportunities while reducing capital burden.

Domestic Companies Highlight Growth Momentum After Listing... How to Secure Additional Buying Power View original image

[Go straight to the No. 1 HighStockLoan service in the industry: https://www.hisl.co.kr]


Meanwhile, interest in stock loans is growing by the day. Investors looking to seize rare investment opportunities without missing them are turning to stock loans, which allow them to utilize greater capital for stock purchases.


Another advantage of stock loans is that, even in the event of a sharp stock price drop during the use of unsettled trades or margin borrowing, investors can simply switch products without providing additional collateral or selling their holdings, and wait for a rebound.


◆ HighStockLoan Offers Additional Investment Funds and Refinances Margin/Unsettled Trades with the Industry's Lowest Annual Interest Rates in the 5% Range!

HighStockLoan has launched a securities-linked credit product that allows any investor to experience stock loans without burden, at the industry's lowest annual interest rates in the 5% range. It can be used not only for stock purchases but also for refinancing margin and unsettled trades at securities firms. Investors can leverage up to four times, including their own capital, without grade-based credit differentiation. Investors currently using the Alternative Trading System (NXT) can also take advantage of this product.


For investors interested in HighStockLoan's wide range of customized products, the customer service center (☎1566-5113) is available 24 hours a day for convenient consultations with professional advisors, regardless of loan eligibility.


○ New products released with the industry's lowest annual interest rates in the 5% range

○ ETF trading available

○ Market share leader for 22 consecutive years, awarded Korea's First Brand Grand Prize for 17 consecutive years

○ Real-time repayment of unsettled trades/margin borrowings at securities firms

○ Alternative Trading System (NXT) trading available

○ Reliable consultation quality guarantee system

* HighStockLoan Consultation Center: 1566-5113

Go straight to service: https://www.hisl.co.kr


Samsung Electro-Mechanics, Sky Labs, Jusung Engineering, HLB, Alteogen



※ The above content is unrelated to the editorial direction of The Asia Business Daily, and all responsibility lies with the information provider.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing